![Olivier Samuel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Olivier Samuel
Inga fler pågående positioner
Förmögenhet: 267 954 $ per 2026-08-31
Profil
Olivier Samuel currently works at NewCelX Ltd., as Independent Director.
Mr. Samuel also formerly worked at Kadimastem Ltd., as Director from 2020 to 2023 and NLS Pharmaceutics Ltd., as Independent Director.
Mr. Samuel received his Masters Business Admin degree in 2002 from EM Lyon Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
1,53 % | 2026-04-29 | 81 818 ( 1,53 % ) | 267 954 $ | 2026-08-31 |
Aktiva positioner av Olivier Samuel
| Företag | Position | Start |
|---|
Tidigare kända positioner av Olivier Samuel
| Företag | Position | Slut |
|---|---|---|
| NLS PHARPAR | Direktör/Styrelseledamot | - |
Kadimastem Ltd.
 Kadimastem Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture of regenerative medicines and develops stem cell-based therapeutics | Direktör/Styrelseledamot | - |
Olivier Samuels utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
22
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
EM Lyon Business School
 EM Lyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kadimastem Ltd.
Kadimastem Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture of regenerative medicines and develops stem cell-based therapeutics | Health Technology |
NLS Pharmaceutics Ltd.
 NLS Pharmaceutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mental and neurobehavioral disorders | Health Technology |
